|
|
|
Agenda: Pre-Conference
Wednesday, November 13, 2002
|
PRECONFERENCE SYMPOSIA
OPTIONAL CONCURRENT SESSIONS - Choose One - 9 a.m. to Noon
|
9:00 a.m. |
Special Pre-Conference Symposium on OIG Model Compliance Guidance
|
|
Marc Farley
Assistant General Counsel
Compliance Officer
Berlex Laboratories, Inc.
Montville, NJ
Stuart Fullerton, Esq.
Senior Litigation Counsel
AstraZeneca Pharmaceuticals, LLP
Wilmington, DE
Michael P. Swiatocha
Director
PricewaterhouseCoopers, LLP
Florham Park, NJ
Chaired by:
John Bentivoglio, Esq.
Partner, Arnold & Porter
Former Special Counsel for Health Care Fraud
Chief Privacy Officer, Department of Justice
Washington, DC
Presentation Material (Acrobat)
Presentation Material (Powerpoint)
Presentation Material (Acrobat)
Presentation Material (Powerpoint)
|
9:00 a.m. |
Special Pre-Conference Symposium on Privacy
|
|
Tom Merchant
R&D Legal Operations US
GlaxoSmithKline
Philadelphia, PA
Leigh-Ann Patterson
Partner
Nixon Peabody LLP
Boston, MA
Presentation Material (Acrobat)
Presentation Material (Powerpoint)
Chaired by:
Brent Saunders, JD, MBA
Partner, PricewaterhouseCoopers, LLP
Founder and 1st VP, International Association of Privacy Officers
Past President, Health Care Compliance Association
Florham Park, NJ
Presentation Material (Acrobat)
Presentation Material (Powerpoint)
|
Noon |
Pre-Conference Adjourns; Lunch on your Own
|
Agenda: Day 1
Wednesday, November 13, 2002
|
PHARMACEUTICAL REGULATORY AND COMPLIANCE CONGRESS AND BEST PRACTICES FORUM
|
1:30 p.m. |
Welcome and Introduction
Bert Weinstein, Esq.
Vice President and Assistant General Counsel
Merck & Co.
Whitehouse Station, NJ
(Conference Co chair)
|
1:45 p.m. |
The OIG's Enforcement Initiatives and Model Guidance in the Pharmaceutical Industry
Janet Rehnquist
Inspector General
Department of Health & Human Services
Washington, DC
|
2:15 p.m. |
Insights into the Department of Justice
Eugene Thirolf
Director
Office of Consumer Litigation, Civil Division
U.S. Department of Justice
Washington, DC
Presentation Material (Acrobat)
Presentation Material (Powerpoint)
|
3:00 p.m. |
Insights into the FDA's DDMAC
Thomas Abrams
Director, Division of Drug Advertising
Marketing & Communications
U.S. Food and Drug Administration
Rockville, MD
Presentation Material (Acrobat)
Presentation Material (Powerpoint)
|
3:45 p.m. |
Break
|
4:00 p.m. |
Regulator Roundtable
Michael Loucks, Esq.
Chief of the Health Care Fraud Unit
Assistant U.S. Attorney
U.S. Attorney's Office for the District of Massachusetts
Boston, MA
Lewis Morris, Esq.
General Counsel
Office Of Inspector General
Department of Health and Human Services
Washington, DC
James Sheehan, Esq.
Chief of the Civil Division
Assistant U.S. Attorney
U.S. Attorney's Office for the Eastern District of Pennsylvania
Philadelphia, PA
David Waterbury, Esq.
Senior Counsel and Director
Washington State Attorney General's Office
Medicaid Fraud Control Unit
Tacoma, WA
John Bentivoglio, Esq.
Partner, Arnold & Porter
Former Special Counsel for Health Care Fraud
Chief Privacy Officer, Department of Justice
Washington, DC
(Moderator)
|
5:30 p.m. |
Adjournment
|
top of page
|
